ATE138059T1 - 3-aryloxazolidinonderivate, verfahren zu ihrer herstellung und ihre anwendung in der heilkunde - Google Patents
3-aryloxazolidinonderivate, verfahren zu ihrer herstellung und ihre anwendung in der heilkundeInfo
- Publication number
- ATE138059T1 ATE138059T1 AT92400721T AT92400721T ATE138059T1 AT E138059 T1 ATE138059 T1 AT E138059T1 AT 92400721 T AT92400721 T AT 92400721T AT 92400721 T AT92400721 T AT 92400721T AT E138059 T1 ATE138059 T1 AT E138059T1
- Authority
- AT
- Austria
- Prior art keywords
- derivatives
- denotes
- alkyl
- forms
- group
- Prior art date
Links
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 3
- 125000000815 N-oxide group Chemical group 0.000 abstract 2
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000002112 pyrrolidino group Chemical group [*]N1C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9104641A FR2675504B1 (fr) | 1991-04-16 | 1991-04-16 | Derives d'aryl-3 oxazolidinone, leur procede de preparation et leur application en therapeutique. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE138059T1 true ATE138059T1 (de) | 1996-06-15 |
Family
ID=9411887
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92400721T ATE138059T1 (de) | 1991-04-16 | 1992-03-18 | 3-aryloxazolidinonderivate, verfahren zu ihrer herstellung und ihre anwendung in der heilkunde |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5264443A (de) |
| EP (1) | EP0511031B1 (de) |
| JP (1) | JPH05112542A (de) |
| KR (1) | KR920019766A (de) |
| AT (1) | ATE138059T1 (de) |
| AU (1) | AU647909B2 (de) |
| CA (1) | CA2065962A1 (de) |
| DE (1) | DE69210675T2 (de) |
| DK (1) | DK0511031T3 (de) |
| ES (1) | ES2087474T3 (de) |
| FR (1) | FR2675504B1 (de) |
| GR (1) | GR3020546T3 (de) |
| NZ (1) | NZ242351A (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2715155B1 (fr) * | 1994-01-19 | 1996-07-26 | Mayoly Spindler | Inhibiteurs de la monoamine oxydase B et leurs procédés de préparation. |
| DK0710657T3 (da) * | 1994-11-02 | 1999-05-25 | Merck Patent Gmbh | Adhæsionsreceptor-antagonister |
| US6455554B1 (en) | 1999-06-07 | 2002-09-24 | Targacept, Inc. | Oxopyridinyl pharmaceutical compositions and methods for use |
| US20070021355A1 (en) * | 2003-05-29 | 2007-01-25 | Hiroaki Kohno | Antidepressants or foods and beverage for antidepression |
| US8188314B2 (en) * | 2008-06-24 | 2012-05-29 | Valeant Pharmaceuticals International | Benzyloxy anilide derivatives useful as potassium channel modulators |
| GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
| KR20220009954A (ko) | 2019-04-17 | 2022-01-25 | 컴퍼스 패쓰파인더 리미티드 | 신경인지 장애, 만성 통증을 치료하고 염증을 감소시키는 방법 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2954381A (en) * | 1958-12-03 | 1960-09-27 | Us Vitamin Pharm Corp | Heteroaryloxazolidinediones |
| US3290326A (en) * | 1963-09-20 | 1966-12-06 | Hoffmann La Roche | Esters of 4-lower alkyl-5-oxazole-car-bamic acid and intermediates therefor |
| US4133675A (en) * | 1976-07-23 | 1979-01-09 | Ciba-Geigy Corporation | Pyridyloxy-phenoxy-alkanecarboxylic acid derivatives which are effective as herbicides and as agents regulating plant growth |
| FR2506769A2 (fr) * | 1978-06-09 | 1982-12-03 | Delalande Sa | Para-((cyano-5 n pentyl-1) phenyl)-3 methoxymethyl-5 oxazolidinone-2, son procede de preparation et ses applications en therapeutique |
| US4348393A (en) * | 1978-06-09 | 1982-09-07 | Delalande S.A. | N-Aryl oxazolidinones, oxazolidinethiones, pyrrolidinones, pyrrolidines and thiazolidinones |
| CA1171865A (en) * | 1980-06-04 | 1984-07-31 | Alain Lacour | N-aryl azolone derivatives, the process for preparing the same and their application in therapeutics |
| FR2608604B1 (fr) * | 1986-12-19 | 1989-04-28 | Delalande Sa | Derives 5-hydroxyethyles de l'oxazolidinone-2, leurs procedes de preparation et leurs applications en therapeutique |
| FR2653017B1 (fr) * | 1989-10-17 | 1995-05-05 | Delalande Sa | Derives d'aryl-3 oxazolidinone-2, leur procede de preparation et leur application en therapeutique. |
-
1991
- 1991-04-16 FR FR9104641A patent/FR2675504B1/fr not_active Expired - Fee Related
-
1992
- 1992-03-18 DK DK92400721.4T patent/DK0511031T3/da active
- 1992-03-18 EP EP92400721A patent/EP0511031B1/de not_active Expired - Lifetime
- 1992-03-18 DE DE69210675T patent/DE69210675T2/de not_active Expired - Fee Related
- 1992-03-18 ES ES92400721T patent/ES2087474T3/es not_active Expired - Lifetime
- 1992-03-18 AT AT92400721T patent/ATE138059T1/de not_active IP Right Cessation
- 1992-04-08 KR KR1019920005842A patent/KR920019766A/ko not_active Application Discontinuation
- 1992-04-09 US US07/865,885 patent/US5264443A/en not_active Expired - Fee Related
- 1992-04-14 NZ NZ242351A patent/NZ242351A/xx unknown
- 1992-04-14 CA CA002065962A patent/CA2065962A1/en not_active Abandoned
- 1992-04-15 AU AU14910/92A patent/AU647909B2/en not_active Ceased
- 1992-04-15 JP JP4095189A patent/JPH05112542A/ja active Pending
-
1996
- 1996-07-16 GR GR960401914T patent/GR3020546T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GR3020546T3 (en) | 1996-10-31 |
| CA2065962A1 (en) | 1992-10-17 |
| KR920019766A (ko) | 1992-11-19 |
| EP0511031A1 (de) | 1992-10-28 |
| FR2675504A1 (fr) | 1992-10-23 |
| DE69210675T2 (de) | 1996-11-28 |
| EP0511031B1 (de) | 1996-05-15 |
| DK0511031T3 (da) | 1996-09-30 |
| US5264443A (en) | 1993-11-23 |
| NZ242351A (en) | 1993-08-26 |
| DE69210675D1 (de) | 1996-06-20 |
| ES2087474T3 (es) | 1996-07-16 |
| AU647909B2 (en) | 1994-03-31 |
| JPH05112542A (ja) | 1993-05-07 |
| AU1491092A (en) | 1992-10-22 |
| FR2675504B1 (fr) | 1995-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE12497T1 (de) | Tricyclische aether, verfahren zu ihrer herstellung und ihre verwendung in heilmitteln. | |
| ATE163012T1 (de) | N-substituierte 4-pyrimidinamine und - pyrimidindiamine, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel | |
| DE3675087D1 (de) | Pyridoncarbonsauere-derivate und verfahren zu ihrer herstellung. | |
| DE3777852D1 (de) | Dekahydrochinolinderivate, verfahren zu ihrer herstellung, zwischenprodukte zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende zubereitungen. | |
| ATE117303T1 (de) | Imidazo(1,2-c>chinazolinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. | |
| ATE138059T1 (de) | 3-aryloxazolidinonderivate, verfahren zu ihrer herstellung und ihre anwendung in der heilkunde | |
| DE3882438D1 (de) | Alkansulfonanilid-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung. | |
| AT389108B (de) | Neue pyridazinonderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen | |
| DE69329231D1 (de) | Pyrazolo(4,3-c)pyridine, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Inhibitoren der Serotonin-Wiederaufnahme | |
| ATE44280T1 (de) | Trizyklische verbindungen, verfahren zur herstellung derselben, pharmazeutische praeparate und behandlungsmethode. | |
| PT73402A (de) | Neue in 5-stellung substituierte 5,10-dihydro-11h-dibenzo/b,e/ /1,4/diazepin-11-one verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
| DE3060153D1 (en) | Derivatives of substituted 2-benzoyl glycinanilides, their preparation and their use in anxiolytic medicaments | |
| ATE40554T1 (de) | Furo(3,2-c>pyridinderivate, ihre herstellung und ihre therapeutische verwendung. | |
| DE68911006D1 (de) | Pharmakologisch-aktive Alkylthiobenzimidazol-Derivate und Verfahren zu deren Herstellung. | |
| ATE36853T1 (de) | Beta-carbolin-3-carbonsaeurederivate und methode zu ihrer herstellung. | |
| ATE20066T1 (de) | Neue basisch substituierte 4-phenyl-4,5,6,7tetrahydrothieno-(2,3-c)pyridine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| DE3675431D1 (de) | 1,3-oxathianderivate. | |
| ATE2431T1 (de) | 2,3-dihydroimidazo (1,2-b) pyridazin-derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung. | |
| ATE123776T1 (de) | Aminoalkylchromone, verfahren zu ihrer herstellung und diese enthaltende zusammensetzungen. | |
| ATE101610T1 (de) | Indol-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate. | |
| ATE73767T1 (de) | Fluorine enthaltende vitamin-d3-derivate und verfahren zu ihrer herstellung. | |
| ATE24487T1 (de) | Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
| DE68906827D1 (de) | Phenothiazinderivate, deren herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
| ATE139780T1 (de) | Amidderivate von 1-amino-octahydropyrido(2,1- c>(1,4>oxazin, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen | |
| ATE134607T1 (de) | Tetrahydronaphtalenderivate, ihre herstellung und ihre therapeutische verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |